Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001415889-25-009991 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-03 | 2025-04-01 | KNSA | Megna Michael R | CAO | F - Tax | $21.77 | -2,084 | 31.3K | -6% | -$45.4K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Megna Michael R | CAO | M - OptEx | — | +4,920 | 32.4K | +18% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -4,920 | 5,115 | -49% | $0 |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Megna Michael R | CAO | A - Grant | $0.00 | +31.7K | 10.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-04-01 | F | D | 1,001 | $21.77 | 30,279 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-04-01 | F | D | 1,083 | $21.77 | 31,280 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-04-01 | M | A | 2,557 | — | 30,000 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 4 | Common | Class A Ordinary Share | 2025-04-01 | M | A | 2,363 | — | 32,363 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 5 | Derivative | Restricted Share Unit | 2025-04-01 | M | D | 2,363 | $0.00 | 7,087 | D | — · — to — | 2,363 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter. |
| 6 | Derivative | Share Option | 2025-04-01 | A | A | 21,150 | $0.00 | 21,150 | D | $21.77 · — to 2035-03-31 | 21,150 Class A Ordinary Share | (F2) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2025. |
| 7 | Derivative | Restricted Share Unit | 2025-04-01 | A | A | 10,575 | $0.00 | 10,575 | D | — · — to — | 10,575 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F3) The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2025. |
| 8 | Derivative | Restricted Share Unit | 2025-04-01 | M | D | 2,557 | $0.00 | 5,115 | D | — · — to — | 2,557 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023. |